Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Allochol is a traditional choleretic combination drug widely used in Russia and CIS countries. It contains four active components: dry bile, dry garlic extract, dry nettle leaf extract, and activated charcoal. The drug works by stimulating the secretory function of liver cells, increasing the production and flow of bile (choleretic and cholagogic effects), and improving the motor and secretory activity of the gastrointestinal tract. It also helps reduce fermentation and putrefaction in the intestines through the adsorbent properties of activated charcoal. It is primarily indicated for the treatment of chronic hepatitis, cholangitis, cholecystitis, and habitual constipation associated with intestinal atony.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Allochol.